Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands
Journal of the European Academy of Dermatology and Venereology Mar 05, 2018
Garritsen FM, et al. - Researchers herein aimed at providing an overview of the use of oral immunosuppressive drugs in patients with atopic dermatitis (AD) in the Netherlands. Findings suggested that oral immunosuppressive drugs were used by 1.4% of the AD patients for their eczema in a five year period. The most commonly used systemic drug in the Netherlands for the treatment of AD was methotrexate.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries